Imende Antoinette Sutherland, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010 Fax: 401-736-4551 |
Dr. Anna R King, D.O. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 200 Crossings Blvd Ste 310, Warwick, RI 02886 Phone: 401-777-7000 |
Miss Karen E Rovani, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 535 Centerville Rd, Suite 101, Warwick, RI 02886 Phone: 401-737-4581 Fax: 401-737-6152 |
News Archive
Cancer is an unwelcome blow for anyone, but those diagnosed with cancer who live in low-income and rural areas face an increased risk of suicide compared with those living in high-income and urban areas, according to a study by The University of Texas Health Science Center at Houston.
ZERO – The End of Prostate Cancer is partnering with Protect Your Manhood, a New Hampshire seacoast based start-up founded by prostatitis survivor and marketing maven Chris Sargent, which offers a culturally relevant resource to promote prostate health.
Psoriasis is a frequent skin inflammatory disorder affecting 3% of the population. Psoriasis is characterized by hyperproliferation and defect of epidermal differentiation, leading to the scaly appearance of the skin. The psoriasis skin also presents an increase in blood vessels, leading to the redness of the skin lesions and is associated with immune infiltration.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited has received pricing approval for NESINA® (alogliptin) in Japan. NESINA, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, received regulatory approval from the Japanese Ministry of Health, Labour and Welfare on April 16, 2010. Furiex collaborated with Takeda to develop this product.
› Verified 6 days ago